BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//wp-events-plugin.com//7.2.2.1//EN
TZID:Europe/Zurich
X-WR-TIMEZONE:Europe/Zurich
BEGIN:VEVENT
UID:19@eso-stroke.org
DTSTART;TZID=Europe/Zurich:20200513T130000
DTEND;TZID=Europe/Zurich:20200513T140000
DTSTAMP:20200513T074112Z
URL:https://eso-stroke.org/events/large-clinical-trials-webinar/
SUMMARY:Large Clinical Trials - Webinar
DESCRIPTION:The webinar is free of charge. No preliminary registration requ
 ired.\n***A few minutes of Q&amp\;A will be allocated after each presentat
 ion. The audience is invited to ask questions at any time using the “cha
 t feature” in the session room. The webinar chairs will ask questions fr
 om this selection during the Q&amp\;A.\nThere have been many recent advanc
 es in stroke care\, and the need for us to provide high-quality care for p
 eople with stroke is as critical now as ever. We are sure you will find th
 ese sessions interesting and exciting during this difficult time where our
  work\, personal\, and social lives are so disrupted.\n\nGet a glimpse of 
 the upcoming ESO-WSO Conference by attending our webinar on Wednesday\, 13
  May at 13:00 pm CET.\n\n\n\nABOUT THIS WEBINAR\n\nWe are delighted to pre
 sent you with five of the highest-rated research works which are part of o
 ur scientific programme\n\n\n\n\n\n\nAGENDA\n\n\n\n 	Welcome and opening r
 emarks from the ESO and WSO Presidents and the Webinar Chairs (3min)\n 	Tr
 ial 1: Efficacy of Fluoxetine: A Randomized Controlled Trial in Stroke (Ef
 fects) Assoc. Prof. Erik Lundström (Sweden) Department of Neuroscience\, 
 Neurology\, Uppsala University\, Akademiska Sjukhuset\, Uppsala\, Sweden\n
  	Trial 2: Assessment of Fluoxetine in Stroke Recovery (Affinity): Results
  of a Double-blind\, Placebo-controlled\, Randomised Trial Prof. Graeme Ha
 nkey (Australia) Department of Neurology\, Medical School\, Faculty of Hea
 lth and Medical Sciences\, The University of Western Australia\n 	Trial 3:
  A Randomized Trial of Direct Endovascular Thrombectomy Versus Thrombectom
 y Preceded by Intravenous Alteplase in Acute Ischemic Stroke Prof. Jianmin
  Liu (China) Changhai Hospital in Shanghai\, Department of Neurosurgery\, 
 Cerebrovascular Center\, China\n 	Trial 4: The Basilar Artery Internationa
 l Collaboration Study (Basics): A Randomized Controlled Trial of Endovascu
 lar Therapy in Basilar Artery Occlusion Dr. Wouter Schonewille (Netherland
 s) Department of Neurology\, St. Antonius Hospital\, Nieuwegein\, The Neth
 erlands\n 	Trial 5: Ascot Trial: The Effect of Randomisation to Atorvastat
 in or Placebo\, and Amlodipine-based or Beta-blocker-based Regime on 20-ye
 ar Incidence of Stroke or Dementia Dr. William Whiteley (UK) Senior Lectur
 er\, CCBS\, University of Edinburgh\, Honorary Consultant Neurologist\, NH
 S Lothian\, Senior Clinical Fellow\, NDPH\, University of Oxford\n 	Closin
 g remarks\n\nLink to webinar can be found on the ESO WSO 2020 Conference w
 ebsite. \n\n\n\n\n
CATEGORIES:ESO Event
END:VEVENT
BEGIN:VTIMEZONE
TZID:Europe/Zurich
X-LIC-LOCATION:Europe/Zurich
BEGIN:DAYLIGHT
DTSTART:20200329T030000
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
END:DAYLIGHT
END:VTIMEZONE
END:VCALENDAR